199 related articles for article (PubMed ID: 32002807)
1. Molecular and Electrophysiological Analyses of ATP2B4 Gene Variants in Bilateral Adrenal Hyperaldosteronism.
Hattangady NG; Foster J; Lerario AM; Ponce-Balbuena D; Rege J; Monticone S; Rainey WE; Mulatero P; Else T
Horm Cancer; 2020 Feb; 11(1):52-62. PubMed ID: 32002807
[TBL] [Abstract][Full Text] [Related]
2. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
[TBL] [Abstract][Full Text] [Related]
3. A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma.
Murakami M; Yoshimoto T; Minami I; Bouchi R; Tsuchiya K; Hashimoto K; Izumiyama H; Fujii Y; Endo T; Akashi T; Nishimoto K; Mukai K; Kihara K; Ogawa Y
Endocr Pathol; 2015 Dec; 26(4):328-33. PubMed ID: 26481629
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
5. Somatic
Nanba K; Blinder AR; Rege J; Hattangady NG; Else T; Liu CJ; Tomlins SA; Vats P; Kumar-Sinha C; Giordano TJ; Rainey WE
Hypertension; 2020 Mar; 75(3):645-649. PubMed ID: 31983310
[TBL] [Abstract][Full Text] [Related]
6. GENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism.
Monticone S; Buffolo F; Tetti M; Veglio F; Pasini B; Mulatero P
Eur J Endocrinol; 2018 Mar; 178(3):R101-R111. PubMed ID: 29348113
[TBL] [Abstract][Full Text] [Related]
7. Somatic and inherited mutations in primary aldosteronism.
Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Mol Endocrinol; 2017 Jul; 59(1):R47-R63. PubMed ID: 28400483
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of bilateral hyperaldosteronism.
Nanba K; Rainey WE
Curr Opin Endocrinol Diabetes Obes; 2022 Jun; 29(3):233-242. PubMed ID: 35621175
[TBL] [Abstract][Full Text] [Related]
9. Genetics of primary aldosteronism.
Funder JW
Front Horm Res; 2014; 43():70-8. PubMed ID: 24943299
[TBL] [Abstract][Full Text] [Related]
10. CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism.
Daniil G; Fernandes-Rosa FL; Chemin J; Blesneac I; Beltrand J; Polak M; Jeunemaitre X; Boulkroun S; Amar L; Strom TM; Lory P; Zennaro MC
EBioMedicine; 2016 Nov; 13():225-236. PubMed ID: 27729216
[TBL] [Abstract][Full Text] [Related]
11. Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca(2+)-ATPase ATP2B3.
Tauber P; Aichinger B; Christ C; Stindl J; Rhayem Y; Beuschlein F; Warth R; Bandulik S
Endocrinology; 2016 Jun; 157(6):2489-99. PubMed ID: 27035656
[TBL] [Abstract][Full Text] [Related]
12. Old and new genes in primary aldosteronism.
Boulkroun S; Fernandes-Rosa FL; Zennaro MC
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101375. PubMed ID: 32007424
[TBL] [Abstract][Full Text] [Related]
13. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
Åkerström T; Willenberg HS; Cupisti K; Ip J; Backman S; Moser A; Maharjan R; Robinson B; Iwen KA; Dralle H; D Volpe C; Bäckdahl M; Botling J; Stålberg P; Westin G; Walz MK; Lehnert H; Sidhu S; Zedenius J; Björklund P; Hellman P
Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
[TBL] [Abstract][Full Text] [Related]
14. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
[TBL] [Abstract][Full Text] [Related]
15. Unravelling the Genetic Basis of Primary Aldosteronism.
Mourtzi N; Sertedaki A; Markou A; Piaditis GP; Charmandari E
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33800142
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations in patients with primary aldosteronism.
Takeda Y
Hypertens Res; 2001 Sep; 24(5):469-74. PubMed ID: 11675938
[TBL] [Abstract][Full Text] [Related]
17. Genetic disorders in primary aldosteronism-familial and somatic.
Funder JW
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):154-157. PubMed ID: 27013018
[TBL] [Abstract][Full Text] [Related]
18. Genetics of mineralocorticoid excess: an update for clinicians.
Zennaro MC; Rickard AJ; Boulkroun S
Eur J Endocrinol; 2013 Jul; 169(1):R15-25. PubMed ID: 23610123
[TBL] [Abstract][Full Text] [Related]
19. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Steroidogenic Characteristics of Aldosterone-Producing Adenomas With ATPase or CACNA1D Gene Mutations.
Kitamoto T; Suematsu S; Yamazaki Y; Nakamura Y; Sasano H; Matsuzawa Y; Saito J; Omura M; Nishikawa T
J Clin Endocrinol Metab; 2016 Feb; 101(2):494-503. PubMed ID: 26606680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
